An obstructive sleep apnea primer: What the practicing allergist needs to know

Annals of Allergy, Asthma & Immunology

March 2017 Volume 118, Issue 3, Pages 259-268 CME Review

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee Members:
Guha Krishnaswamy, MD (Author)
Sara Pasha, MD (Author)
Arjun B. Chatterjee, MD (Author)
Sandhya Kumar, MD (Author)
Anne K. Ellis, MD (Associate Editor)
Jonathan A. Bernstein, MD (CME Subcommittee)
John J. Oppenheimer, MD (CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:
Recognize patients at high risk for obstructive sleep apnea
Recommend appropriate diagnostic tests and treatment for obstructive sleep apnea

Additional information
Disclosure: 

G. Krishnaswamy, received research grant from CSL. Behring; S. Pasha, A. Chatterjee, S. Kumar have nothing to disclose. M.H. Grayson has received research grants from Children’s Research Institute/Medical College of Wisconsin, Merck, National Institutes of Health (NIH), and Polyphor. G.D. Marshall has received research grants from Amgen, AstraZeneca, HRSA and National Institutes of Health (NIH). J.J. Oppenheimer has been a consultant/advisor for AstraZeneca, GlaxoSmithKline, Meda, Mylan, and Sunovion; has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis. A.K. Ellis has received research grants from Circassia, Sun Pharma Advanced Research, Merck, Novartis, Pfizer, and GlaxoSmithKline; has also been a consultant/advisor for Circassia, Merck, Novartis, and GlaxoSmithKline; and has been a speaker for Merck, Novartis, Takeda and AstraZeneca. J.A. Bernstein, Reviewers and Education/Editorial staff have no relevant financial relationships to disclose. No unapproved/investigative use of a product/device is discussed. 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
03/01/2017
Course expires: 
02/28/2019
Cost:
$0.00
Rating: 
0

Planning Committee Members:
Guha Krishnaswamy, MD (Author)
Sara Pasha, MD (Author)
Arjun B. Chatterjee, MD (Author)
Sandhya Kumar, MD (Author)
Anne K. Ellis, MD (Associate Editor)
Jonathan A. Bernstein, MD (CME Subcommittee)
John J. Oppenheimer, MD (CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
03/01/2017
Course expires: 
02/28/2019

Price

Cost:
$0.00
Please login or create an account to take this course.